HMG CoA reductase inhibitors (statins) for dialysis patients
Sankar D. Navaneethan(Baylor College of Medicine), Giovanni FM Strippoli(The University of Sydney)
Cited by 158
Related Papers
Heart Disease and Stroke Statistics—2021 Update
|Circulation|2021|5.7k
Multinational Assessment of Accuracy of Equations for Predicting Risk of Kidney Failure
|JAMA|2016|696
Comparative efficacy and safety of blood pressure-lowering agents in adults with diabetes and kidney disease: a network meta-analysis
|The Lancet|2015|394
Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies
|The Lancet Diabetes & Endocrinology|2019|320
Effect of Hemodiafiltration or Hemodialysis on Mortality in Kidney Failure
|New England Journal of Medicine|2023|273